Supplementary tables: Efficacy of tucatinib for HER2-positive metastatic breast cancer after HER2-targeted therapy: a network meta-analysis.docx

Name: Supplementary tables: Efficacy of tucatinib for HER2-positive metastatic breast cancer after HER2-targeted therapy: a network meta-analysis.docx
Creator: Taylor & Francis
Published: 2024-05-15 14:06:38
License: 暂无描述

DataCite Commons2024-05-15 更新2025-04-15 收录

下载链接：

https://tandf.figshare.com/articles/dataset/Supplementary_tables_Efficacy_of_tucatinib_for_HER2-positive_metastatic_breast_cancer_after_HER2-targeted_therapy_a_network_meta-analysis_docx/16546077

下载链接

链接失效反馈

官方服务：

资源简介：

Supplementary Table 1. Search terms used in Embase (A) Initial systematic review search, January 22, 2020; (B, C) November 23, 2020 Supplementary Table 2. Systematic literature review eligibility criteria used to identify relevant randomized trials Supplementary Table 3. Risk of bias assessment for studies included in the NMA

提供机构：

Taylor & Francis

创建时间：

2021-08-31